Thrombate Iii Generic Name & Formulations
Antithrombin III (human) 500 IU, 1000 IU; per vial; lyophilized pwd for IV infusion after reconstitution; preservative-free.
Thrombin inhibitor (α2-glycoprotein).
Single-use vial—1 (w. diluent, needles)
Thrombate Iii Indications
Treatment of patients with hereditary antithrombin III deficiency (AT-III) in surgical or obstetrical procedures and thromboembolism.
Thrombate Iii Dosage and Administration
Give by IV infusion over 10–20 minutes. Individualized. Dose (units required)= [desired (% of normal) – baseline (% of normal) AT-III level] X weight (kg)/1.4. Loading dose: increase AT-III to 120% of normal. Subsequent dose should be based on AT-III levels obtained 20 minutes post-infusion, every 12hrs, and before the next dose. Maintain AT-III levels at 80–120% of normal for 2–8 days.
Thrombate Iii Contraindications
Thrombate Iii Boxed Warnings
Thrombate Iii Warnings/Precautions
Surgery. Hemorrhage. Acute thrombosis. Monitor AT-III levels during treatment. Contains human plasma; monitor for possible infection transmission. Pregnancy (Cat.B).
Thrombate Iii Pharmacokinetics
Thrombate Iii Interactions
Potentiates anticoagulant effect of heparin; reduce heparin dose.
Thrombate Iii Adverse Reactions
Dizziness, chest tightness, nausea, taste disturbances, chills, cramps, shortness of breath, chest pain, light-headedness, bowel fullness, hives, fever, hematoma formation.
Thrombate Iii Clinical Trials
Thrombate Iii Note
Report all infections suspected to be transmitted by Thrombate III to (800) 520-2807.
Thrombate Iii Patient Counseling